Abstract:Chronic fibrosis can lead to organ failure and is also associated with cancer, where the tumor is interpreted as a chronic wound, and the fibrotic tumor environment drives disease progression. Fibrosis occurs in an inflammatory environment where macrophages are activated, and fibroblasts transdifferentiate into myofibroblasts. Activated macrophages stimulate the myofibroblasts to produce excessive amounts of collagen-rich ECM. Changes in proteolytic activity and high contractile forces that myofibroblasts apply onto their tissue environment, further lead to extensive remodeling of the healthy tissue matrix into a scar matrix. Similar activity is displayed by cancer-associated fibroblasts (CAFs) in tumors. Intervening with the excessive ECM remodeling by activated fibroblasts represents a candidate therapeutic strategy to normalize the architecture of fibrotic and malignant tissues. We developed a screening platform using an assay based on automated image guided injection of clusters of fibroblasts in wells of multi-well plates preloaded with a collagen-rich ECM network. The identical x-y-z position, spacing, and size of the ECM-embedded fibroblast clusters in each well facilitates automated real time confocal microscopy and quantitative image analysis algorithms. We use this setup for automated quantitative analysis of ECM remodeling activity of CAFs obtained from early-stage colorectal cancer patients. We find that CAFs from these early-stage lesions display increased ECM remodeling capacity as compared to patient matched normal fibroblasts. We then use the same setup to screen a series of compounds for their ability to attenuate ECM remodeling triggered by TGFb-activated primary human fibroblasts. We detect known and novel pathways, and we identify small molecule inhibitors with a promising efficacy versus toxicity profile. Lastly, we detect a previously unknown concentration-dependent side effect of ALK5 inhibitors that leads to the identification of a novel profibrotic pathway and indicates that caution is warranted for the clinical application of ALK5 inhibitors. Citation Format: Erik H. J. Danen. Arrays of 3D ECM-embedded fibroblast clusters for characterization of ECM remodeling by primary cancer associated fibroblasts and for evaluation of drugs attenuating fibrotic ECM remodeling [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 737.

MFAP4-Mediated Effects in Elastic Fiber Homeostasis, Integrin Signaling and Cancer, and Its Role in Teleost Fish

Microfibrillar-associated protein 4 in health and disease

Bidirectional Roles of Skeletal Muscle Fibro-Adipogenic Progenitors in Homeostasis and Disease.

Microfibril-associated glycoprotein 4 forms octamers that mediate interactions with elastogenic proteins and cells

Microfibril-associated glycoprotein 4 (Mfap4) regulates haematopoiesis in zebrafish

MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation

Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).

Integrated Analysis of Microfibrillar-Associated Proteins Reveals MFAP4 As a Novel Biomarker in Human Cancers

Microfibrillar-associated Protein 4 (MFAP4) Genes in Catfish Play a Novel Role in Innate Immune Responses

MFAP4 Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Through Regulation of Macrophage Infiltration and Activity

MFAP5 in Cancer-associated Fibroblasts Regulates the Progression of the PDAC

Mechanical Stiffness Promotes Skin Fibrosis Through FAPα-AKT Signaling Pathway.

Microfibril-Associated Protein-3-Like Regulates TGF β -Induced EMT Process via TNFR2/p38 MAPK Pathway in Endothelial Cells

Matrix Metalloproteinases and Their Effects in Myocardial Fibrosis

A multifactorial analysis of FAP to regulate gastrointestinal cancers progression

MFAP5 Promotes Tumor Progression and Bone Metastasis by Regulating ERK/MMP Signaling Pathways in Breast Cancer.

MFAP4 deficiency alleviates renal fibrosis through inhibition of NF‐κB and TGF‐β/Smad signaling pathways

Abstract 737: Arrays of 3D ECM-embedded fibroblast clusters for characterization of ECM remodeling by primary cancer associated fibroblasts and for evaluation of drugs attenuating fibrotic ECM remodeling

Involvement of lysophosphatidic acid-LPA 1 -YAP signaling in healthy and pathological FAPs migration

Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer

The Role Of Fibulin-1C Peptides In Attachment, Proliferation And ECM Deposition In Lung Fibroblasts From Chronic Lung Diseases